中商官网
研究报告
港通医疗（301515）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2012 | 265000000.0000 | 40432500.0000 | 41199800.0000 | 30247800.0000 | 480000000.0000 | 268000000.0000 | 212000000.0000 |
| 2013 | 317000000.0000 | 37032500.0000 | 39002200.0000 | 31945700.0000 | 553000000.0000 | 309000000.0000 | 244000000.0000 |
| 2014 | 376000000.0000 | 42556800.0000 | 44426900.0000 | 37170100.0000 | 541000000.0000 | 268000000.0000 | 273000000.0000 |
| 2015 | 339000000.0000 | 38379700.0000 | 35150300.0000 | 28879800.0000 | 535000000.0000 | 233000000.0000 | 302000000.0000 |
| 2016 | 362000000.0000 | 48541400.0000 | 53004700.0000 | 44405300.0000 | 557000000.0000 | 214000000.0000 | 343000000.0000 |
| 2018 | 394000000.0000 | 27245400.0000 | 26871100.0000 | 23872000.0000 | 713000000.0000 | 371000000.0000 | 342000000.0000 |
| 2019 | 457000000.0000 | 39727300.0000 | 39927300.0000 | 34648900.0000 | 757000000.0000 | 389000000.0000 | 368000000.0000 |
| 2020 | 562000000.0000 | 73769100.0000 | 75935700.0000 | 65288000.0000 | 917000000.0000 | 491000000.0000 | 426000000.0000 |
| 2021 | 681000000.0000 | 77449600.0000 | 81609800.0000 | 71678400.0000 | 1003000000.0000 | 519000000.0000 | 484000000.0000 |
| 2022 | 769000000.0000 | 83590800.0000 | 83299800.0000 | 73927800.0000 | 1163000000.0000 | 609000000.0000 | 554000000.0000 |
| 2023 | 842000000.0000 | 97305200.0000 | 94865900.0000 | 83097200.0000 | 1997000000.0000 | 668000000.0000 | 1329000000.0000 |
| 2024 | 754000000.0000 | 13332600.0000 | 15100800.0000 | 14421900.0000 | 1947000000.0000 | 662000000.0000 | 1285000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2012 | 10.19 | 15.55 | 8.58 | 11.5700 | 0.9600 | 2.59 | 0.55 |
| 2013 | 11.67 | 12.30 | 7.05 | 14.0300 | 1.1700 | 2.60 | 0.57 |
| 2014 | 11.17 | 11.82 | 8.21 | 14.3800 | 1.7200 | 2.26 | 0.70 |
| 2015 | 11.50 | 10.37 | 6.57 | 10.0300 | 2.0300 | 1.59 | 0.63 |
| 2016 | 13.54 | 14.64 | 9.52 | 13.7700 | 2.5900 | 1.46 | 0.65 |
| 2018 | 6.09 | 6.82 | 3.77 | 7.2300 | 1.4900 | 1.54 | 0.55 |
| 2019 | 8.32 | 8.74 | 5.27 | 9.7400 | 1.6600 | 1.61 | 0.60 |
| 2020 | 12.10 | 13.51 | 8.28 | 16.4400 | 1.7800 | 1.72 | 0.61 |
| 2021 | 10.87 | 11.98 | 8.14 | 15.7500 | 2.0900 | 1.77 | 0.68 |
| 2022 | 10.40 | 10.83 | 7.16 | 14.1900 | 2.4000 | 1.53 | 0.66 |
| 2023 | 7.84 | 11.27 | 4.75 | 9.4100 | 2.4100 | 1.31 | 0.42 |
| 2024 | 0.53 | 2.00 | 0.78 | 1.1000 | 2.4200 | 1.06 | 0.39 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2012 | 55.83 | 44.17 | 1.6300 | 0.8300 |
| 2013 | 55.88 | 44.12 | 1.6300 | 0.9000 |
| 2014 | 49.54 | 50.46 | 1.8600 | 1.2700 |
| 2015 | 43.55 | 56.45 | 2.0600 | 1.5600 |
| 2016 | 38.42 | 61.58 | 2.2700 | 1.7900 |
| 2018 | 52.03 | 47.97 | 1.6700 | 1.0700 |
| 2019 | 51.39 | 48.61 | 1.7100 | 1.0900 |
| 2020 | 53.54 | 46.46 | 1.6800 | 1.1200 |
| 2021 | 51.74 | 48.26 | 1.7200 | 1.1700 |
| 2022 | 52.36 | 47.64 | 1.7500 | 1.3400 |
| 2023 | 33.45 | 66.55 | 2.8900 | 2.4000 |
| 2024 | 34.00 | 66.00 | 2.8000 | 2.4400 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2012 | 238000000.0000 | 21270000.0000 | 17224700.0000 | -280000.0000 |
| 2013 | 280000000.0000 | 23413000.0000 | 21307900.0000 | 2043200.0000 |
| 2014 | 334000000.0000 | 24948300.0000 | 25551100.0000 | 17700.0000 |
| 2015 | 300000000.0000 | 21605200.0000 | 27856700.0000 | 3493000.0000 |
| 2016 | 313000000.0000 | 23624600.0000 | 31298400.0000 | 2847000.0000 |
| 2018 | 370000000.0000 | 30805400.0000 | 26404200.0000 | 2199200.0000 |
| 2019 | 419000000.0000 | 33777100.0000 | 28169700.0000 | 3383100.0000 |
| 2020 | 494000000.0000 | 38171800.0000 | 30551500.0000 | 3777800.0000 |
| 2021 | 607000000.0000 | 39948400.0000 | 30838200.0000 | 4416200.0000 |
| 2022 | 689000000.0000 | 46129200.0000 | 31466800.0000 | 4727300.0000 |
| 2023 | 776000000.0000 | 53564000.0000 | 37257600.0000 | 4189300.0000 |
| 2024 | 750000000.0000 | 39985400.0000 | 31796400.0000 | -4276800.0000 |